Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 5374176, 9 pages
https://doi.org/10.1155/2017/5374176
Review Article

Cardiac Autonomic Neuropathy: Why Should Cardiologists Care about That?

Department of Interventional Cardiology and Arrhythmias, Medical University of Lodz, Lodz, Poland

Correspondence should be addressed to Andrzej Bissinger; moc.liamg@regnissiba

Received 11 March 2017; Revised 6 May 2017; Accepted 21 May 2017; Published 29 October 2017

Academic Editor: Norman Cameron

Copyright © 2017 Andrzej Bissinger. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Global report on diabetes. WHO Library Cataloguing-in-Publication Data, World Health Organization 2016,” http://www.who.int/diabetes/publications/grd-2016/en/.
  2. P. Gaede, P. Vedel, N. Larsen, G. V. Jensen, H. H. Parving, and O. Pedersen, “Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes,” The New England Journal of Medicine, vol. 348, no. 5, pp. 383–393, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. I. Vinik and T. Erbas, “Chapter 22 - diabetic autonomic neuropathy,” Handbook of Clinical Neurology, vol. 117, pp. 27–94, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Spallone, D. Ziegler, R. Freeman et al., “Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 7, pp. 639–653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Pop-Busui, “Cardiac autonomic neuropathy in diabetes: a clinical perspective,” Diabetes Care, vol. 33, no. 2, pp. 434–441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. I. Vinik, R. Freeman, and T. Erbas, “Diabetic autonomic neuropathy,” Seminars in Neurology, vol. 23, no. 4, pp. 365–372, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Ziegler, “Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment,” Diabetes/Metabolism Reviews, vol. 10, no. 4, pp. 339–383, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Balcıoğlu and H. Müderrisoğlu, “Diabetes and cardiac autonomic neuropathy: clinical manifestations, cardiovascular consequences, diagnosis and treatment,” World Journal of Diabetes, vol. 6, no. 1, pp. 80–91, 2015. View at Publisher · View at Google Scholar
  9. G. Dimitropoulos, A. A. Tahrani, and M. J. Stevens, “Cardiac autonomic neuropathy in patients with diabetes mellitus,” World Journal of Diabetes, vol. 5, no. 1, pp. 17–39, 2014. View at Publisher · View at Google Scholar
  10. The DiabetesControl and Complications Trial Research Group, “The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT),” Diabetologia, vol. 41, no. 4, pp. 416–423, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. R. E. Maser, M. A. Pfeifer, J. S. Dorman, L. H. Kuller, D. J. Becker, and T. J. Orchard, “Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III,” Archives of Internal Medicine, vol. 150, no. 6, pp. 1218–1222, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Kempler, S. Tesfaye, N. Chaturvedi et al., “Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study,” Diabetic Medicine, vol. 19, no. 11, pp. 900–909, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Pop-Busui, G. W. Evans, H. C. Gerstein et al., “Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial,” Diabetes Care, vol. 33, no. 7, pp. 1578–1584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. W. Albers and R. Pop-Busui, “Diabetic neuropathy: mechanisms, emerging treatments, and subtypes,” Current Neurology and Neuroscience Reports, vol. 14, no. 8, p. 473, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. S. L. Cichosz, J. Frystyk, L. Tarnow, and J. Fleischer, “Are changes in heart rate variability during hypoglycemia confounded by the presence of cardiovascular autonomic neuropathy in patients with diabetes?” Diabetes Technology & Therapeutics, vol. 19, no. 2, pp. 91–95, 2017. View at Publisher · View at Google Scholar
  16. M. Jaiswal, K. McKeon, N. Comment et al., “Association between impaired cardiovascular autonomic function and hypoglycemia in patients with type 1 diabetes,” Diabetes Care, vol. 37, no. 9, pp. 2616–2621, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. F. J. T. Wackers, L. H. Young, S. E. Inzucchi et al., “Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study,” Diabetes Care, vol. 27, no. 8, pp. 1954–1961, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. P. C. Deedwania and E. V. Carbajal, “Silent ischemia during daily life is an independent predictor of mortality in stable angina,” Circulation, vol. 81, no. 3, pp. 748–756, 1990. View at Publisher · View at Google Scholar
  19. W. B. Kannel and R. D. Abbott, “Incidence and prognosis of unrecognized myocardial infarction — an update on the Framingham Study,” The New England Journal of Medicine, vol. 311, no. 18, pp. 1144–1147, 1984. View at Publisher · View at Google Scholar
  20. H. Miettinen, S. Lehto, V. Salomaa et al., “Impact of diabetes on mortality after the first myocardial infarction,” Diabetes Care, vol. 21, no. 1, pp. 69–75, 1998. View at Publisher · View at Google Scholar
  21. A. I. Vinik and D. Ziegler, “Diabetic cardiovascular autonomic neuropathy,” Circulation, vol. 115, no. 3, pp. 387–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. M. Dayem, A. A. Battah, and M. Bohy Ael, “Cardiovascular autonomic neuropathy and early atherosclerosis in adolescent type 1 diabetic patient,” Open Access Macedonian Journal of Medical Sciences, vol. 3, no. 4, pp. 681–688, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. H. M. Colhoun, D. P. Francis, M. B. Rubens, S. R. Underwood, and J. H. Fuller, “The association of heart-rate variability with cardiovascular risk factors and coronary artery calcification: a study in type 1 diabetic patients and the general population,” Diabetes Care, vol. 24, no. 6, pp. 1108–1114, 2001. View at Publisher · View at Google Scholar
  24. K. Kacem, G. Bonvento, and J. Seylaz, “Effect of sympathectomy on the phenotype of smooth muscle cells of middle cerebral and ear arteries of hyperlipidaemic rabbits,” The Histochemical Journal, vol. 29, no. 4, pp. 279–286, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Dimitriadou, P. Aubineau, J. Taxi, and J. Seylaz, “Ultrastructural changes in the cerebral artery wall induced by long-term sympathetic denervation,” Blood Vessels, vol. 25, no. 3, pp. 122–143, 1988. View at Google Scholar
  26. J. Colombo, R. Arora, N. L. DePace, and C. Ball, Clinical Autonomic Dysfunction, Springer International Publishing, Switzerland, 2014.
  27. V. Spallone, L. Bernardi, L. Ricordi et al., “Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy,” Diabetes, vol. 42, no. 12, pp. 1745–1752, 1993. View at Publisher · View at Google Scholar
  28. C. T. Prince, A. M. Secrest, R. H. Mackey, V. C. Arena, L. A. Kingsley, and T. J. Orchard, “Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes,” Diabetes Care, vol. 33, no. 3, pp. 652–657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Meyer, F. Milat, B. P. McGrath, J. Cameron, D. Kotsopoulos, and H. J. Teede, “Vascular dysfunction and autonomic neuropathy in type 2 diabetes,” Diabetic Medicine, vol. 21, no. 7, pp. 746–751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. A. R. Ahlgren, G. Sundkvist, P. Wollmer, B. Sonesson, and T. Länne, “Increased aortic stiffness in women with type 1 diabetes mellitus is associated with diabetes duration and autonomic nerve function,” Diabetic Medicine, vol. 16, no. 4, pp. 291–297, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. C. D. Stehouwer, R. M. Henry, and I. Ferreira, “Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease,” Diabetologia, vol. 51, no. 4, pp. 527–539, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Pop-Busui, “What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes,” Journal of Cardiovascular Translational Research, vol. 5, no. 4, pp. 463–478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Pop-Busui, P. A. Cleary, B. H. Braffett et al., “Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications),” Journal of the American College of Cardiology, vol. 61, no. 4, pp. 447–454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Frustaci, J. Kajstura, C. Chimenti et al., “Myocardial cell death in human diabetes,” Circulation Research, vol. 87, no. 12, pp. 1123–1132, 2000. View at Publisher · View at Google Scholar
  35. P. Coumel, “Autonomic influences in atrial tachyarrhythmias,” Journal of Cardiovascular Electrophysiology, vol. 7, no. 10, pp. 999–1007, 1996. View at Publisher · View at Google Scholar
  36. A. Bissinger, T. Grycewicz, W. Grabowicz, and A. Lubinski, “The effect of diabetic autonomic neuropathy on P-wave duration, dispersion and atrial fibrillation,” Archives of Medical Science, vol. 7, no. 5, pp. 806–812, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. R. E. Maser, B. D. Mitchell, A. I. Vinik, and R. Freeman, “The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis,” Diabetes Care, vol. 26, no. 6, pp. 1895–1901, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. S. S. Soedamah-Muthu, N. Chaturvedi, D. R. Witte et al., “Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS),” Diabetes Care, vol. 31, no. 7, pp. 1360–1366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. C. W. Israel and Y. H. Lee-Barkey, “Sudden cardiac death in diabetes mellitus,” Herz, vol. 41, no. 3, pp. 193–200, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Veglio, M. Borra, L. K. Stevens, J. H. Fuller, and P. C. Perin, “The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group,” Diabetologia, vol. 42, no. 1, pp. 68–75, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. J. M. Pappachan, J. Sebastian, B. C. Bino et al., “Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis,” Postgraduate Medical Journal, vol. 84, no. 990, pp. 205–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Bissinger, L. Markuszewski, and M. Rosiak, “Value and circadian variations of QT dispersion in patients with diabetes mellitus and coronary artery disease,” Polski Merkuriusz Lekarski, vol. 24, no. 140, pp. 90–94, 2008. View at Google Scholar
  43. M. M. Page and P. J. Watkins, “Cardiorespiratory arrest and diabetic autonomic neuropathy,” Lancet, vol. 1, no. 8054, pp. 14–16, 1978. View at Publisher · View at Google Scholar · View at Scopus
  44. I. A. O'Brien, J. P. McFadden, and R. J. M. Corrall, “The influence of autonomic neuropathy on mortality in insulin-dependent diabetes,” QJM: An International Journal of Medicine, vol. 79, no. 3, pp. 495–502, 1991. View at Publisher · View at Google Scholar · View at Scopus
  45. D. J. Ewing, I. W. Campbell, and B. F. Clarke, “Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications,” Annals of Internal Medicine, vol. 92, no. 2, Part 2, pp. 308–311, 1980. View at Publisher · View at Google Scholar
  46. A. J. M. Boulton, A. I. Vinik, J. C. Arezzo et al., “Diabetic neuropathies: a statement by the American Diabetes Association,” Diabetes Care, vol. 28, no. 4, pp. 956–962, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Tesfaye, A. J. Boulton, P. J. Dyck et al., “Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments,” Diabetes Care, vol. 33, no. 10, pp. 2285–2293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. A. S. Menon, A. Dixit, M. K. Garg, and R. Girish, “Cardiac autonomic neuropathy in patients with type 2 diabetes mellitus at high risk for foot ulcers,” Indian Journal of Endocrinology and Metabolism, vol. 21, no. 2, pp. 282–285, 2017. View at Publisher · View at Google Scholar
  49. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, “Heart rate variability: standards of measurement, physiological interpretation and clinical use,” Circulation, vol. 93, no. 5, pp. 1043–1065, 1996. View at Publisher · View at Google Scholar
  50. K. Howorka, J. Pumprla, A. Schabmann, and H. Thoma, “Development of an analytic standard for evaluating heart rate variability in cardiovascular autonomic neuropathy in diabetes: comparison of short-term spectral analysis with Ewing’s standard battery of reflex tests as reference method,” Biomedizinische Technik/Biomedical Engineering, vol. 43, pp. 568-569, 1998. View at Publisher · View at Google Scholar
  51. S. Sammito and I. Böckelmann, “Reference values for time- and frequency-domain heart rate variability measures,” Heart Rhythm, vol. 13, no. 6, pp. 1309–1316, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Bernardi, V. Spallone, M. Stevens et al., “Methods of investigation for cardiac autonomic dysfunction in human research studies,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 7, pp. 654–664, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Borowik, W. Grabowicz, T. Grycewicz, and A. Lubiński, “Clinical usefulness of baroreflex sensitivity test in the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus,” Polski Merkuriusz Lekarski, vol. 39, no. 233, pp. 277–280, 2015. View at Google Scholar
  54. J. Gerritsen, J. M. Dekker, B. J. TenVoorde et al., “Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study,” Diabetes Care, vol. 24, no. 10, pp. 1793–1798, 2001. View at Publisher · View at Google Scholar
  55. A. Bauer, M. Malik, G. Schmidt et al., “Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus,” Journal of the American College of Cardiology, vol. 52, no. 17, pp. 1353–1365, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Bissinger, J. Ruxer, R. B. Ahmed, and A. Lubinski, “Heart rate turbulence in patients with poorly controlled diabetes mellitus type 2,” Archives of Medical Science, vol. 10, no. 6, pp. 1073–1077, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Balcioğlu, U. Arslan, S. Türkoğlu, M. Ozdemir, and A. Cengel, “Heart rate variability and heart rate turbulence in patients with type 2 diabetes mellitus with versus without cardiac autonomic neuropathy,” The American Journal of Cardiology, vol. 100, no. 5, pp. 890–893, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. American Diabetes Association, “10. Microvascular complications and foot care,” Diabetes Care, vol. 40, Supplement 1, pp. S88–S98, 2017. View at Publisher · View at Google Scholar
  59. D. Ziegler, F. A. Gries, M. Spüler, and F. Lessmann, “The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group,” Journal of Diabetes and its Complications, vol. 6, no. 1, pp. 49–57, 1992. View at Google Scholar
  60. W. R. Kennedy, X. Navarro, and D. E. Sutherland, “Neuropathy profile of diabetic patients in a pancreas transplantation program,” Neurology, vol. 45, no. 4, pp. 773–780, 1995. View at Publisher · View at Google Scholar
  61. P. A. Low, L. M. Benrud-Larson, D. M. Sletten et al., “Autonomic symptoms and diabetic neuropathy: a population-based study,” Diabetes Care, vol. 27, no. 12, pp. 2942–2947, 2004. View at Publisher · View at Google Scholar · View at Scopus